Filing Flows › AbbVie (ABBV) › How it makes money
How AbbVie (ABBV) makes money
AbbVie (ABBV) made $17.4B of revenue in the third quarter 2026 (Q3 2026), +10% from a year earlier. Of every dollar of revenue, 36¢ was left as operating profit, 24¢ was left as net earnings.
Drawing the Sankey…
Where each dollar of revenue goes
| Line | Q3 2026 | % of revenue |
|---|---|---|
| Revenue | $17.4B | 100.0% |
| Operating profit | $6.3B | 36.0% |
| Income tax | $609M | 3.5% |
| Net earnings | $4.2B | 24.2% |
| Operating cash flow | $7.6B | 43.7% |
| Free cash flow | $7.3B | 42.0% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q3 2026 | $17.4B | +10% |
| Q2 2026 | $17.0B | +10% |
| Q1 2026 | $15.0B | +12% |
| Q4 2025 | $16.6B | +10% |
| Q3 2025 | $15.8B | +9% |
| Q2 2025 | $15.4B | +7% |
| Q1 2025 | $13.3B | +8% |
From AbbVie's 10-Q filed Nov 3, 2026 (on EDGAR).
Questions
How does AbbVie make money?
AbbVie (ABBV) made $17.4B of revenue in the third quarter 2026 (Q3 2026), +10% from a year earlier. Of every dollar of revenue, 36¢ was left as operating profit, 24¢ was left as net earnings.
What is AbbVie's profit margin?
Net earnings were $4.2B, 24.2% of revenue, in the third quarter 2026; the operating margin was 36.0%.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.